METHOD FOR PRODUCING PARVOVIRUS CHARACTERIZED BY HIGH INFECTIVITY TITRE AND HIGH PURITY Russian patent published in 2019 - IPC C12N7/00 

Abstract RU 2701948 C1

FIELD: biotechnology.

SUBSTANCE: invention relates to biotechnology and specifically to a method of producing parvovirus derived from an unconjugated cell culture supernatant. Method comprises (a) a pre-calculation step every 24 hours of a time-dependent change in cell density in a culture substrate, when host cells are infected with parvovirus for each cell density (A) when infected with a virus; (b) a step for determining, based on the time-dependent change in cell density, calculated at step (a), (b1), the time (Tmax) from infection to time of peak time-dependent change in cell density, (b2) cell density (Bmax) at Tmax and A1, which is A, which satisfies following equation (1) Bmax/A1>1.2, (b3) maximum (Amax) cell density A1 when infected with virus and (b4) A2, which satisfies following equation (2) Amax≥A2≥Amax/10; (c) a stage of inoculation of seed parvovirus into a culture substrate containing host cells having cell density A2, wherein the infecting virus defined in (b4) of step (b) and the serum medium give a multiplicity of infection (MOI) of 0.001 to 0.1; (d) a cultivation stage of a cultured product containing host cells and parvovirus obtained at step (c) for a period of time Tmax or more to less than (Tmax+48) hours, where Tmax is defined in (b1) of step (b); (e) a step for replacing the culture supernatant obtained in step (d) with a serum-free medium and culturing for 12 hours or more; and (f) a step for collecting a parvovirus-containing culture supernatant produced by culturing at step (e); where at step (b), when A satisfying equation (1) is absent, steps (a) and (b) are repeated by using another density of cells A when infected with virus.

EFFECT: invention enables to obtain parvovirus with high infectivity titre for use in evaluating viral safety of pharmaceutical or biological products or when producing vaccines.

9 cl, 10 tbl, 4 ex

Similar patents RU2701948C1

Title Year Author Number
METHOD FOR MAKING RECOMBINANT ADENOVIRUS PREPARATION CHARACTERISED BY LOWER RATIO OF PHYSICAL AND INFECTIOUS VIRAL PARTICLES, AND GENETICALLY THERAPEUTIC DRUG PREPARATION PRODUCED BY SUCH METHOD 2009
  • Narodnitskij Boris Savel'Evich
  • Shmarov Maksim Mikhajlovich
  • Logunov Denis Jur'Evich
  • Viskova Natal'Ja Jur'Evna
  • Alekseeva Marina Viktorovna
  • Barykova Julija Aleksandrovna
  • Gintsburg Aleksandr Leonidovich
RU2443779C2
METHOD FOR VIRUS REPLICATION IN AVIAN EMBRYO STEM CELLS 2006
  • Mekhtali Madzhid
  • Shamp'On-Arno Patrik
  • Leon Arno
RU2457253C2
METHOD OF PRODUCING MATERIAL WITH HIGH TITRE OF HEPATITIS E VIRUS AND ANALYSIS OF HEPATITIS E VIRUS TITRATION 2016
  • Buno Brett
  • Journigan Terri
  • Hotta Joann
  • Burdick Michael
RU2691123C1
TWO-STAGE TEMPERATURE PROFILE OF VIRAL CULTIVATION 2008
  • Rajter Manfred
  • Grill'Berger Leopol'D
  • Mundt Vol'Fgang
RU2476594C2
METHOD OF OPTIMIZING LARGE-SCALE PRODUCTION OF PARVOVIRUS H-1 IN SUBSTANTIALLY SERUM-FREE MEDIUM 2017
  • Leuchs, Barbara
  • Rommelaere, Jean
  • Lutz, Sebastian
  • Vogel, Martin
RU2714111C1
METHODS FOR RELEASE OF VIRUS-LIKE PARTICLES 2014
  • Fakhinger Vikki
  • Sno Melani
RU2648143C2
METHOD OF PROTEIN EXPRESSION 2007
  • Grill'Berger Leopol'D
  • Rajter Manfred
  • Mundt Vol'Fgang
  • Mitterer Artur
RU2486236C2
ANTIVIRAL COMPOSITION 2012
  • Thomas Becky Mary
  • Saklani Arvind
  • Kapoor Natasha
  • Enose Arno Appavoo
  • Sawant Satish Namdeo
  • Kaushik Ritu
  • Bhowmick Rupa
  • Malani Ashish
RU2584245C2
METHOD OF PRODUCING CONTINUOUS CELL LINES AND USE THEREOF 2009
  • Rajter Manfred
  • Mundt Vol'Fgang
  • Fajgl' Zimone
  • Fon Firks Zimone
RU2509803C2
METHOD OF MASS PRODUCTION OF MULTIMEASURED MANNAN-BINDING LECTINE 2004
  • Moon Khong Mo
  • Jum Dzung Sun
  • Akhn Biung Cheol
  • Li Dzoo Joun
  • Joon Dzaeseung
RU2350654C2

RU 2 701 948 C1

Authors

Sawamura, Yoshiyuki

Yanagida, Koichiro

Dates

2019-10-02Published

2016-10-05Filed